INOVIOPossible readd on a retracement if we find support at retracement levels. Could break out of wedge structure and long way to find resistance on macro levels
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−93.66MXN
−2.29 BMXN
14.13 MMXN
25.74 M
About Inovio Pharmaceuticals, Inc.
Sector
CEO
Jacqueline E. Shea
Headquarters
Plymouth Meeting
Website
Founded
1983
FIGI
BBG00SNGSN42
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases associated with human papillomavirus. Its product pipeline includes VGX-3100, INO-3107, INO-5410, INO-4800, and PENNVAX-GP. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
INO Inovio Pharmaceuticals Options Ahead of EarningsAnalyzing the options chain and the chart patterns of INO Inovio Pharmaceuticals prior to the earnings report this week,
I would consider purchasing the 13usd strike price Calls with
an expiration date of 2024-5-17,
for a premium of approximately $0.25.
If these options prove to be profitable prior
$INO 50% upside potentialNASDAQ:INO had a streak of green weeks recently and currently is trading above a significant resistance at $11.96
- MACD weekly just turned positive
- Vortex index is positive
INO 1D 2 Month Larger TF shows continuation. Time/Space corrective until wave (B). Breakout of falling wedge finished. Retracement and continuation.
Inovio Pharmaceuticals, Inc. engages in the provision of designed DNA medicines to treat and protect people from infectious diseases, cancer, and diseases a
INO Bullish Deep CrabINO has completed a bottom formation IMO. I believe the bottom has come in a harmonic deep crab formation. I've highlighted the accumulation zone. This is high risk but also has the potential of being a 5 to 100x bagger. Good Luck!
💊 INO SELL THE BREAK 📉INO has broken out of a larger degree correction and continues to make smaller degree flags in the bearish direction.
Stick to your trading rules!
Inovio timeCovid is here to stay!
Data from the WHO will be good. Time to buy and hold. Let the shorts
See all ideas
An aggregate view of professional's ratings.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of INO is 110.00 MXN — it has decreased by −8.33% in the past 24 hours. Watch INOVIO PHARMACEUTICALS INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on BMV exchange INOVIO PHARMACEUTICALS INC stocks are traded under the ticker INO.
INO stock has fallen by −3.20% compared to the previous week, the month change is a −5.17% fall, over the last year INOVIO PHARMACEUTICALS INC has showed a 30.95% increase.
We've gathered analysts' opinions on INOVIO PHARMACEUTICALS INC future price: according to them, INO price has a max estimate of 655.53 MXN and a min estimate of 139.05 MXN. Watch INO chart and read a more detailed INOVIO PHARMACEUTICALS INC stock forecast: see what analysts think of INOVIO PHARMACEUTICALS INC and suggest that you do with its stocks.
INO stock is 9.09% volatile and has beta coefficient of 1.48. Track INOVIO PHARMACEUTICALS INC stock price on the chart and check out the list of the most volatile stocks — is INOVIO PHARMACEUTICALS INC there?
Today INOVIO PHARMACEUTICALS INC has the market capitalization of 2.75 B, it has increased by 0.03% over the last week.
Yes, you can track INOVIO PHARMACEUTICALS INC financials in yearly and quarterly reports right on TradingView.
INOVIO PHARMACEUTICALS INC is going to release the next earnings report on Nov 5, 2024. Keep track of upcoming events with our Earnings Calendar.
INO earnings for the last quarter are −21.83 MXN per share, whereas the estimation was −20.21 MXN resulting in a −8.02% surprise. The estimated earnings for the next quarter are −22.66 MXN per share. See more details about INOVIO PHARMACEUTICALS INC earnings.
INOVIO PHARMACEUTICALS INC revenue for the last quarter amounts to 1.85 M MXN, despite the estimated figure of 2.46 M MXN. In the next quarter, revenue is expected to reach 2.22 M MXN.
INO net income for the last quarter is −591.29 M MXN, while the quarter before that showed −504.97 M MXN of net income which accounts for −17.09% change. Track more INOVIO PHARMACEUTICALS INC financial stats to get the full picture.
No, INO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 2, 2024, the company has 122.00 employees. See our rating of the largest employees — is INOVIO PHARMACEUTICALS INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. INOVIO PHARMACEUTICALS INC EBITDA is −2.10 B MXN, and current EBITDA margin is −15.83 K%. See more stats in INOVIO PHARMACEUTICALS INC financial statements.
Like other stocks, INO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade INOVIO PHARMACEUTICALS INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So INOVIO PHARMACEUTICALS INC technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating INOVIO PHARMACEUTICALS INC stock shows the sell signal. See more of INOVIO PHARMACEUTICALS INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.